| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers C > Headlines for Ciphergen Biosystems, Inc. > News item |
Ciphergen warned by Nasdaq on listing
New York, May 31 - Ciphergen Biosystems, Inc. said it was warned that it is out of compliance with the listing standards for the Nasdaq National Market.
In a letter from the Nasdaq Listings Qualification Department, the Fremont, Calif., provider of diagnostic tests for patients and research said it was told the value of its listed securities has fallen below the required level of $50 million for 10 consecutive business days.
Ciphergen has 30 calendar days - up to June 23 - to regain compliance.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.